[Clinical observation of surgical resection combined radiofrequency in patients with CNLC â
¡a~â
¢a stage multiple hepatocellular carcinoma].
Zhonghua Yi Xue Za Zhi
; 101(28): 2195-2202, 2021 Jul 27.
Article
em Zh
| MEDLINE
| ID: mdl-34333931
ABSTRACT
Objective:
To investigate the effects of four therapeutic methods in the comprehensive treatment of China liver cancer staging (CNLC)â ¡a~â ¢a stage multiple hepatocellular carcinoma.Method:
A retrospective study was conducted to collect clinical data of patients with multiple hepatocellular carcinoma (CNLC stage â ¡a-â ¢a), who received transhepatic arterial chemoembolization (TACE group, 73 cases), radiofrequency ablation (RFA group, 70 cases), TACE combined RFA (TACE combined RFA group, 69 cases) and surgical resection combined RFA (surgical resection combined RFA group, 57 cases) in the First Hospital of Lanzhou University from January 11, 2010 to January 31, 2017. The general data of age, gender, primary tumor, and laboratory examination were collected. The differences in overall survival rates and the survival rates among stratified subgrouping with different clinical factors between the four groups of patients were compared by the Kaplan-Meier method. Cox proportional hazards regression model analyzed the prognostic factors.Result:
A total of 269 patients were enrolled and there were 194 males and 59 females with a median age of 58 years ranging from 23 to 84. The TACE group's 1, 3, and 5-year survival rates were 43.5%, 10.2%, and 0, respectively. The RFA group were 46.3%, 17.7%, and 0, respectively. The TACE combined RFA group were 56.8%, 21.5%, and 2.3%, respectively. The surgical resection combined RFA group was 76.5%, 38.7%, and 3.8%, respectively. The surgical resection combined RFA group has the best outcome(P<0.05). Univariate analysis showed that surgery combined RFA, tumor diameter<5 cm, no vascular invasion, preoperative AFP≤400 µg/L and TB<34 µmol/L are protective factors to improve the survival prognosis of patients with CNLCâ ¡a~â ¢a stage multiple hepatocellular carcinoma(HR=0.784,0.718,0.633,0.846,0.617;all P<0.05). Multivariate Cox analysis showed that surgery combined RFA, tumor diameter<5 cm, preoperative AFP≤400 µg/L were independent risk prognostic factors for CNLCâ ¡a-â ¢a stage multiple hepatocellular carcinoma (HR=0.702,0.743,0.647;all P<0.05).Conclusions:
Surgical resection combined RFA is an effective method for the treatment of stage â ¡a-â ¢a hepatocellular carcinoma. Surgical resection combined RFA has more advantages in treatment patients with complicated hepatocellular carcinoma whose diameter<5 cm, tumor number<3, and preoperative AFP≤400 µg/L. Surgical resection combined RFA, tumor diameter<5 cm, preoperative AFP≤400 µg/L are independent influencing factors for the survival prognosis of patients with complicated hepatocellular carcinoma.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Quimioembolização Terapêutica
/
Ablação por Cateter
/
Carcinoma Hepatocelular
/
Neoplasias Hepáticas
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
Asia
Idioma:
Zh
Revista:
Zhonghua Yi Xue Za Zhi
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
China